Stock listing

NASDAQ:SILO Silo Pharma, Inc. Stock

Home listing (NASDAQ) of Silo Pharma, Inc.

Follow Silo Pharma, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:SILO

$1.71 USD -0.18 (-9.5%)

Close on Nov 20, 2026

Past year -68.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.67 – $1.82 USDNov 20, 2026
Volume
41,635 sharesNov 20, 2026
Market cap
$3.77M USDAt the close on Nov 20, 2026 · price × 2.20M shares outstanding
52-week range
$1.10 – $10.42 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$106,856 USDMedian day 28,800 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Silo Pharma, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:SILO · Home$1.71 USD-0.18 (-9.5%)41,635$1.78$1.82$1.67$1.89Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:SILO · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.71-0.18-9.5%$1.78$1.82$1.6741,635
$1.89+0.18+10.5%$1.765$1.91$1.6449,806
$1.71+0.135+8.6%$1.61$1.72$1.5332,759
$1.575-0.265-14.4%$1.76$1.839$1.48569,529
$1.84-0.07-3.7%$1.89$1.92$1.7648,848
$1.91+0.068+3.7%$1.90$1.95$1.79565,040
$1.842+0.052+2.9%$1.84$1.976$1.72147,476
$1.79+0.16+9.8%$1.67$1.839$1.58134,542
$1.63+0.30+22.6%$1.385$1.71$1.385176,035
$1.33+0.04+3.1%$1.26$1.365$1.2521,170
$1.29-0.04-3.0%$1.219$1.40$1.18537,725
$1.33+0.05+3.9%$1.212$1.34$1.21218,311
$1.28+0.07+5.8%$1.21$1.291$1.2121,275
$1.21-0.02-1.6%$1.244$1.285$1.20611,578
$1.23-0.02-1.6%$1.24$1.25$1.19812,039
$1.25-0.09-6.7%$1.31$1.32$1.2515,465
$1.34+0.05+3.9%$1.26$1.377$1.2611,478
$1.29+0.13+11.2%$1.15$1.29$1.1421,697
$1.16-0.02-1.7%$1.142$1.175$1.1426,225
$1.180.000.0%$1.17$1.195$1.176,600
$1.18-0.02-1.7%$1.20$1.22$1.1723,700
$1.200.000.0%$1.19$1.232$1.1837,200
$1.20+0.07+6.2%$1.151$1.21$1.1499,500
$1.13-0.05-4.2%$1.20$1.205$1.1318,900
$1.18-0.02-1.7%$1.22$1.23$1.1710,200
$1.200.000.0%$1.20$1.235$1.1514,100
$1.20-0.02-1.6%$1.22$1.26$1.2064,800
$1.22-0.27-18.1%$1.41$1.43$1.10153,900
$1.49+0.02+1.4%$1.47$1.49$1.4222,200
$1.47+0.02+1.4%$1.44$1.48$1.39517,000
$1.45+0.01+0.7%$1.43$1.451$1.3714,300
$1.44-0.01-0.7%$1.43$1.46$1.4122,400
$1.45-0.04-2.7%$1.50$1.50$1.4027,600
$1.49+0.032+2.2%$1.35$1.51$1.30207,900
$1.458-0.042-2.8%$1.50$1.57$1.451,152,700
$1.50-0.01-0.7%$1.51$1.60$1.47544,200
$1.51-0.10-6.2%$1.60$1.60$1.463205,600
$1.61-0.04-2.4%$1.71$1.71$1.6129,000
$1.65-0.10-5.7%$1.74$1.789$1.6522,700
$1.750.000.0%$1.81$1.81$1.7220,100
$1.75-0.02-1.1%$1.79$1.83$1.7224,600
$1.77+0.05+2.9%$1.74$1.84$1.7444,400
$1.72-0.025-1.4%$1.77$1.77$1.7142,900
$1.745-0.095-5.2%$1.77$1.84$1.7264,400
$1.84+0.12+7.0%$1.70$1.90$1.662282,000
$1.72-0.04-2.3%$1.82$1.88$1.6651,000
$1.76-0.18-9.3%$1.97$1.97$1.6380,700
$1.94-0.13-6.3%$2.09$2.09$1.9140,200
$2.07-0.03-1.4%$2.08$2.20$2.0528,800
$2.10-0.004-0.2%$2.19$2.19$2.0536,600
$2.104-0.046-2.1%$2.18$2.39$2.1019,600
$2.15-0.13-5.7%$2.34$2.34$2.1439,900
$2.28-0.12-5.0%$2.33$2.356$2.2220,600
$2.40-0.05-2.0%$2.45$2.50$2.20535,500
$2.45-0.05-2.0%$2.51$2.54$2.3715,000
$2.50+0.06+2.5%$2.46$2.50$2.465,400
$2.44-0.04-1.6%$2.56$2.56$2.447,800
$2.48-0.06-2.4%$2.48$2.55$2.4722,600
$2.540.000.0%$2.54$2.58$2.47518,800
$2.54+0.04+1.6%$2.44$2.57$2.43318,100
$2.50-0.09-3.5%$2.59$2.752$2.4938,400
$2.59+0.01+0.4%$2.52$2.63$2.4656,100
$2.58-0.07-2.6%$2.64$2.732$2.50145,400
$2.65-0.09-3.3%$2.77$2.887$2.6063,300
$2.74-0.12-4.2%$2.80$2.82$2.7032,700

Splits

1 split · NASDAQ:SILO · every price before a split is adjusted for it

DayRatioWhat
1-for-15Consolidation
Ticker
NASDAQ:SILO
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Silo Pharma, Inc. news

Silo Pharma, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
22 in the last 12 months · 153 in all · newest Sep 30, 2026 · oldest 2020
Decks
6 decks · latest March 2026

Where Silo Pharma, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:SILO · Home listing · This pageNASDAQUnited StatesUSD
BOATS:SILOBOATSUnited StatesUSD

Valuation

Price/book 0.5× against a median of 0.8×: 3rd lowest of 10 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$4.28M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
0.5×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.23

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Silo Pharma, Inc. · NASDAQ:SILOUS$3.77M−US$4.28Mn/an/an/a0.5×n/a0.0×1.23
Processa Pharmaceuticals, Inc. · NASDAQ:PCSAUS$4.37M−US$175.8Mn/an/an/an/an/an/a1.60
AdAlta Ltd. · ASX:1ADUS$4.25MUS$3.40Mn/an/an/a17.4×n/a0.0×n/a
Percheron Therapeutics Limited · ASX:PERUS$3.94MUS$1.27Mn/an/an/a0.8×n/a0.0×n/a
Lantern Pharma Inc. · NASDAQ:LTRNUS$3.89M−US$3.69Mn/an/an/a2.8×n/a0.0×2.80
Alzamend Neuro, Inc. · NASDAQ:ALZNUS$3.74M−US$3.85Mn/an/an/a0.7×n/a0.0×2.00
Biotron Limited · ASX:BITUS$3.69MUS$2.66Mn/an/an/a1.9×n/a0.0×n/a
Reviva Pharmaceuticals Holdings, Inc. · NASDAQ:RVPHUS$3.68M−US$13.77Mn/an/an/a0.3×n/a0.0×1.57
Liminatus Pharma, Inc. · NASDAQ:LIMNUS$3.37MUS$1.80Mn/an/an/a11.2×n/a4.8×0.94
Xenetic Biosciences, Inc. · NASDAQ:XBIOUS$3.28M−US$2.53Mn/a−0.8×n/a0.7×−123.7%0.0×1.46
Aprea Therapeutics, Inc. · NASDAQ:APREUS$3.25M−US$34.60Mn/an/an/a0.1×n/a0.0×0.73
Median of the othersUS$3.72M−US$3.11M−0.8×0.8×−123.7%0.0×1.57

Team and board

Officers

OfficerRole
Eric WeisblumCEO
James KuoVice President of R&D

Board

DirectorRole
Eric WeisblumCEO
Jeff Pavell D.O.Member
Kevin MuñozBoard Member
Wayne D. LinsleyBoard Member

Events

QuarterResultsShare move
Q3 2026Nov 13, 2026−17.5%
Q2 2026Aug 13, 2026+3.4%
Q1 2026May 29, 2026−21.5%
Q3 2025Dec 3, 2025−0.9%
Q2 2025Aug 13, 2025+2.7%
Q1 2025May 9, 2025+31.3%
Q4 2024Mar 28, 2025−11.4%
Q3 2024Nov 27, 2024+13.6%
Q2 2024Aug 28, 2024−15.5%
Q1 2024May 29, 2024+2.0%
All 20 quarters
QuarterResultsShare move
Q4 2023Mar 25, 2024 · After close+0.5%
Q3 2023Nov 13, 2023 · After close−3.4%
Q2 2023Aug 12, 2023 · Before open−2.5%
Q1 2023May 31, 2023+2.6%
Q4 2022Mar 24, 2023−1.5%
Q3 2022Nov 10, 2022+1.9%
Q2 2022Aug 1, 2022−5.8%
Q1 2022May 13, 20220.0%
Q4 2021Mar 28, 2022+25.0%
Quarter to Sep 30, 2021Nov 10, 2021−0.5%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (March 2026)Investor deck18 slidesMarch 2026
Investor Presentation (March 2025)Investor deck17 slidesMar 10, 2025
Investor Presentation (March 2025)Investor deck18 slidesMarch 2025
Investor Presentation (September 2024)Investor deck18 slidesSep 10, 2024
Investor Presentation (October 2022)Investor deck24 slidesOct 18, 2022
Investor Presentation (June 2022)Investor deck19 slidesJun 1, 2022

Open Decks

Financings

RaiseDate
Private placement of common stock (or pre-funded warrants) with Series A-3 and Series A-4 warrants
Announced: about US$4M · US$6.452 a share · Warrants at US$6.21 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and general corporate purposes
Jul 10, 2026
Registered direct offering of shares of common stock with concurrent unregistered warrants
Closed: US$2.5M raised · US$0.875 a share · Warrants at US$0.75 for 60 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and general corporate purposes
Oct 1, 2025
Public offering of shares of common stock (or pre-funded warrants) with series A-1 and A-2 warrants
Closed: US$2M raised · US$0.6 a share · Warrants at US$0.6 for 60 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: General working capital purposes
May 16, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue72.1K72.1K72.1K72.1K71.3K40.9K40.6K0847.4K-669.5K
Cost of revenue44.3K5.84K5.84K5.84K5.00K176.1K27.4K17.6K
Gross profit27.8K66.3K66.3K66.3K66.3K-135.2K13.2K-17.6K847.4K-669.5K
Research and development2.16M2.37M845.1K1.29M693.9K26.3K63.5K
Selling, general and administrative2.15M2.40M390.1K227.3K163.0K50.2K864.2K459.8K313.4K301.0K
Operating income-4.28M-4.71M-3.86M-3.63M-2.74M-2.20M-930.4K-594.2K-490.9K-393.7K
Depreciation and amortization11.4K6.18K90.1K72.6K108.0K578.9K61.9K17.6K17.6K393.7K
EBITDA-4.27M-4.70M-3.77M-3.56M-2.64M-1.62M-868.5K-576.7K-473.3K0
Interest expense37.3K5.08K4.87K2.20K3.04K8004.22K20.5K49.8K
Income before tax-4.23M-4.39M-3.63M-3.91M4.18M-2.67M-1.01M-969.5K356.5K-1.11M
Income tax69.6K1.16K24.9K92.3K34.8K-513.9K-62.9K
Net income-4.23M-4.39M-3.70M-3.91M3.90M-3.04M-1.01M-969.5K356.5K-1.11M
Earnings per share, basic-0.50-1.19-1.20-1.240.04-0.05-0.04-0.020.01-16.63
Earnings per share, diluted-0.50-1.19-1.200.04-0.05-0.04-0.020.01

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents4.75M3.91M3.52M11.4M9.84M1.13M111.8K336.7K294.6K579.2K
Short-term investments2.11M3.17M4.14M3.12K420.0K2009.39K228.3K1.32M
Receivables66.0K61.2K23.5K200.0K58.5K
Inventory-61.2K33.5K156.4K27.0K
Current assets7.39M7.11M7.68M11.6M10.4M1.43M493.8K626.0K1.64M664.7K
Total assets7.61M7.41M7.75M11.6M10.5M1.43M493.8K855.4K1.64M1.30M
Accounts payable578.1K1.58M703.5K364.2K417.9K127.1K54.9K25.6K38.3K53.1K
Current liabilities650.2K1.66M775.6K436.3K490.0K141.7K116.7K48.0K38.3K53.1K
Long-term debt4.25K
Total debt18.9K61.9K22.3K
Total liabilities1.30M2.38M1.57M1.30M1.43M146.0K116.7K448.0K438.3K453.1K
Shareholders' equity6.31M5.03M6.18M10.3M9.06M1.28M-22.9K407.4K1.20M846.5K
Shares outstanding887.9K4.48M2.91M3.16M1.97M85.1M23.6M23.4M50.1M66.9K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-4.66M-3.83M-3.22M-3.50M-2.28M-1.16M-794.3K272.6K-284.6K-143.6K
Capital spending-574.9K000-400000
Free cash flow-4.66M-3.83M-3.22M-3.50M-2.28M-1.16M-794.3K272.6K-284.6K-143.6K
Cash from investing644.0K973.8K-4.15M86.7K7.19M39.0K186.7K-250.0K157.6K344.5K
Cash from financing4.86M3.24M-471.1K4.94M3.79M2.13M382.7K19.5K19.5K0
Dividends paid-2.18K
Share buybacks0-173.1K-471.1K00-2.87K
Change in cash842.9K381.5K-7.84M1.53M8.71M1.02M-224.9K42.1K-284.6K-143.6K

Open Financials

Filings

FilingDateTypeFiled with
S-3 · Registration statementNov 18, 2026Offer documentSEC
SCHEDULE 13G · Big-stake noticeNov 16, 2026Big-stake noticeSEC
10-Q · Quarterly reportNov 13, 2026Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 10, 2026Big-stake noticeSEC
8-K · Current reportNov 6, 2026Material contractSEC
8-K · Current reportOct 14, 2026Material contractSEC
8-K · Current reportOct 2, 2026Material contractSEC
8-K · Current reportAug 19, 2026Material contractSEC
8-K · Current reportAug 17, 2026Meeting outcomeSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
Show 200 filings
FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedAug 13, 2026Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveAug 7, 2026Other filingsSEC
424B3 · ProspectusAug 6, 2026Offer documentSEC
S-8 · Registration statement for employee plansJul 31, 2026Offer documentSEC
S-3 · Registration statementJul 24, 2026Offer documentSEC
DJul 14, 2026Other filingsSEC
8-K · Current reportJul 10, 2026Material contractSEC
SCHEDULE 13G · Big-stake noticeJul 8, 2026Big-stake noticeSEC
ARS · Annual report to shareholdersJun 30, 2026Annual reportSEC
DEFA14A · Additional proxy materialJun 30, 2026Meeting noticeSEC
DEF 14A · Proxy statementJun 30, 2026Meeting noticeSEC
8-K · Current reportJun 18, 2026Current reportSEC
PRE 14A · Preliminary proxy statementJun 18, 2026Meeting noticeSEC
8-K · Current reportJun 3, 2026Current reportSEC
8-K · Current reportJun 1, 2026Current reportSEC
10-Q · Quarterly reportMay 13, 2026Quarterly reportSEC
424B3 · ProspectusApr 16, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveApr 16, 2026Other filingsSEC
424B3 · ProspectusApr 14, 2026Offer documentSEC
POS AM · Amendment to an effective registrationApr 14, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveApr 14, 2026Other filingsSEC
POS AM · Amendment to an effective registrationApr 10, 2026Offer documentSEC
8-K · Current reportApr 2, 2026Material contractSEC
10-K · Annual reportMar 27, 2026Annual reportSEC
8-K · Current reportFeb 23, 2026FinancingSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
8-K · Current reportDec 29, 2025Current reportSEC
4 · Change in ownershipDec 16, 2025Insider tradeSEC
EFFECT · Notice that a registration is effectiveNov 28, 2025Other filingsSEC
424B3 · ProspectusNov 26, 2025Offer documentSEC
CORRESP · Letter to the SECNov 24, 2025Other filingsSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
4 · Change in ownershipNov 20, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeNov 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 7, 2025Big-stake noticeSEC
S-1 · Registration statementOct 28, 2025Offer documentSEC
8-K · Current reportOct 24, 2025Management or board changeSEC
SCHEDULE 13G · Big-stake noticeOct 3, 2025Big-stake noticeSEC
8-K · Current reportOct 1, 2025Material contractSEC
424B5 · ProspectusOct 1, 2025Offer documentSEC
DEFA14A · Additional proxy materialSep 5, 2025Meeting noticeSEC
ARS · Annual report to shareholdersSep 5, 2025Annual reportSEC
DEF 14A · Proxy statementSep 5, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementAug 25, 2025Meeting noticeSEC
424B5 · ProspectusAug 18, 2025Offer documentSEC
10-Q · Quarterly reportAug 13, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 12, 2025Big-stake noticeSEC
8-K · Current reportAug 5, 2025Current reportSEC
8-K · Current reportJul 29, 2025Material contractSEC
8-K · Current reportJul 10, 2025Material contractSEC
8-K · Current reportJul 3, 2025Current reportSEC
4 · Change in ownershipMay 28, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeMay 21, 2025Big-stake noticeSEC
8-K · Current reportMay 16, 2025Material contractSEC
424B4 · ProspectusMay 16, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveMay 16, 2025Other filingsSEC
CORRESP · Letter to the SECMay 12, 2025Other filingsSEC
S-1/A · Registration statement, amendedMay 9, 2025Offer documentSEC
10-Q · Quarterly reportMay 9, 2025Quarterly reportSEC
CORRESP · Letter to the SECApr 30, 2025Other filingsSEC
S-1/A · Registration statement, amendedApr 29, 2025Offer documentSEC
CORRESP · Letter to the SECApr 28, 2025Other filingsSEC
S-1 · Registration statementApr 25, 2025Offer documentSEC
UPLOAD · Letter from the SECApr 17, 2025Other filingsSEC
DRS · Draft registration statementApr 11, 2025Offer documentSEC
424B3 · ProspectusApr 4, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveApr 4, 2025Other filingsSEC
POS AM · Amendment to an effective registrationMar 28, 2025Offer documentSEC
10-K · Annual reportMar 28, 2025Annual reportSEC
8-K · Current reportMar 10, 2025Current reportSEC
8-K · Current reportMar 7, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2025Big-stake noticeSEC
8-K · Current reportJan 2, 2025Current reportSEC
8-K · Current reportDec 20, 2024Meeting outcomeSEC
4 · Change in ownershipDec 16, 2024Insider tradeSEC
4 · Change in ownershipNov 22, 2024Insider tradeSEC
DEFR14ANov 15, 2024Meeting noticeSEC
SCHEDULE 13G · Big-stake noticeNov 13, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 12, 2024Quarterly reportSEC
DEFA14A · Additional proxy materialNov 8, 2024Meeting noticeSEC
8-K · Current reportNov 8, 2024Current reportSEC
ARS · Annual report to shareholdersSep 18, 2024Annual reportSEC
DEFA14A · Additional proxy materialSep 18, 2024Meeting noticeSEC
DEF 14A · Proxy statementSep 18, 2024Meeting noticeSEC
8-K · Current reportSep 10, 2024Current reportSEC
424B3 · ProspectusSep 4, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveSep 4, 2024Other filingsSEC
CORRESP · Letter to the SECAug 29, 2024Other filingsSEC
UPLOAD · Letter from the SECAug 28, 2024Other filingsSEC
S-1 · Registration statementAug 21, 2024Offer documentSEC
10-Q · Quarterly reportAug 13, 2024Quarterly reportSEC
DAug 2, 2024Other filingsSEC
EFFECT · Notice that a registration is effectiveJul 31, 2024Other filingsSEC
424B3 · ProspectusJul 30, 2024Offer documentSEC
SC 13G · Big-stake noticeJul 26, 2024Big-stake noticeSEC
CORRESP · Letter to the SECJul 26, 2024Other filingsSEC
S-1/A · Registration statement, amendedJul 25, 2024Offer documentSEC
8-K · Current reportJul 22, 2024Material contractSEC
UPLOAD · Letter from the SECJul 22, 2024Other filingsSEC
424B5 · ProspectusJul 22, 2024Offer documentSEC
S-1 · Registration statementJul 17, 2024Offer documentSEC
8-K · Current reportJul 8, 2024Material contractSEC
8-K · Current reportJun 27, 2024Material contractSEC
SC 13G · Big-stake noticeJun 13, 2024Big-stake noticeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
DJun 11, 2024Other filingsSEC
8-K · Current reportJun 6, 2024Material contractSEC
424B5 · ProspectusJun 6, 2024Offer documentSEC
8-K · Current reportJun 4, 2024Current reportSEC
10-Q · Quarterly reportMay 13, 2024Quarterly reportSEC
4 · Change in ownershipApr 8, 2024Insider tradeSEC
8-K · Current reportApr 5, 2024Current reportSEC
4 · Change in ownershipApr 1, 2024Insider tradeSEC
10-K · Annual reportMar 25, 2024Annual reportSEC
8-K · Current reportFeb 1, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveJan 31, 2024Other filingsSEC
CORRESP · Letter to the SECJan 26, 2024Other filingsSEC
S-3/A · Registration statement, amendedJan 25, 2024Offer documentSEC
SC 13G/A · Big-stake notice, amendedJan 25, 2024Big-stake noticeSEC
UPLOAD · Letter from the SECJan 25, 2024Other filingsSEC
S-3 · Registration statementJan 23, 2024Offer documentSEC
8-K/A · Current report, amendedJan 11, 2024Current reportSEC
8-K · Current reportJan 9, 2024Current reportSEC
4 · Change in ownershipDec 21, 2023Insider tradeSEC
8-K12BDec 20, 2023Other filingsSEC
4 · Change in ownershipDec 18, 2023Insider tradeSEC
8-K · Current reportDec 11, 2023Meeting outcomeSEC
4 · Change in ownershipDec 7, 2023Insider tradeSEC
8-K · Current reportDec 5, 2023Current reportSEC
8-K · Current reportDec 4, 2023Meeting outcomeSEC
4 · Change in ownershipNov 30, 2023Insider tradeSEC
4 · Change in ownershipNov 27, 2023Insider tradeSEC
4 · Change in ownershipNov 22, 2023Insider tradeSEC
4 · Change in ownershipNov 20, 2023Insider tradeSEC
8-K · Current reportNov 14, 2023Material contractSEC
10-Q · Quarterly reportNov 13, 2023Quarterly reportSEC
DEFA14A · Additional proxy materialOct 23, 2023Meeting noticeSEC
DEF 14A · Proxy statementOct 23, 2023Meeting noticeSEC
PRE 14A · Preliminary proxy statementOct 10, 2023Meeting noticeSEC
8-K · Current reportAug 31, 2023Current reportSEC
10-Q · Quarterly reportAug 11, 2023Quarterly reportSEC
8-K · Current reportJun 29, 2023Current reportSEC
4 · Change in ownershipMay 26, 2023Insider tradeSEC
4 · Change in ownershipMay 18, 2023Insider tradeSEC
10-Q · Quarterly reportMay 12, 2023Quarterly reportSEC
8-K · Current reportMar 27, 2023Current reportSEC
10-K · Annual reportMar 24, 2023Annual reportSEC
8-K · Current reportFeb 15, 2023Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2023Big-stake noticeSEC
8-K · Current reportFeb 3, 2023Current reportSEC
8-K · Current reportJan 31, 2023Current reportSEC
8-K · Current reportJan 20, 2023Current reportSEC
4 · Change in ownershipDec 20, 2022Insider tradeSEC
4 · Change in ownershipDec 15, 2022Insider tradeSEC
8-K · Current reportDec 1, 2022Current reportSEC
SC 13G · Big-stake noticeNov 15, 2022Big-stake noticeSEC
10-Q · Quarterly reportNov 10, 2022Quarterly reportSEC
8-K · Current reportOct 18, 2022Material contractSEC
3 · Initial statement of ownershipOct 4, 2022Insider tradeSEC
3 · Initial statement of ownershipOct 4, 2022Insider tradeSEC
8-K · Current reportSep 30, 2022Material contractSEC
424B4 · ProspectusSep 28, 2022Offer documentSEC
CERT · Exchange's certificate of listingSep 27, 2022Other filingsSEC
EFFECT · Notice that a registration is effectiveSep 27, 2022Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeSep 26, 2022Other filingsSEC
CORRESP · Letter to the SECSep 22, 2022Other filingsSEC
CORRESP · Letter to the SECSep 22, 2022Other filingsSEC
S-1/A · Registration statement, amendedSep 20, 2022Offer documentSEC
8-K · Current reportSep 15, 2022Current reportSEC
S-1/A · Registration statement, amendedSep 8, 2022Offer documentSEC
S-1/A · Registration statement, amendedAug 26, 2022Offer documentSEC
10-Q · Quarterly reportAug 1, 2022Quarterly reportSEC
S-1/A · Registration statement, amendedJul 22, 2022Offer documentSEC
4 · Change in ownershipJun 21, 2022Insider tradeSEC
10-Q · Quarterly reportMay 13, 2022Quarterly reportSEC
10-K · Annual reportMar 28, 2022Annual reportSEC
8-K · Current reportMar 11, 2022Meeting outcomeSEC
DEFA14A · Additional proxy materialMar 7, 2022Meeting noticeSEC
8-K · Current reportMar 7, 2022Current reportSEC
DEF 14A · Proxy statementFeb 14, 2022Meeting noticeSEC
PRE 14A · Preliminary proxy statementFeb 2, 2022Meeting noticeSEC
4/A · Change in ownership, amendedJan 5, 2022Insider tradeSEC

This page holds 200 of 383 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Silo Pharma, Inc.’s releases · as of Jul 10, 2026

Common shares
2,203,250
Fully diluted
2,203,250

Fully diluted

LineShares
Common shares2,203,250

Warrants and options

Lot
Warrants · US$0.75 · expire about Oct 2030
Warrants · US$0.60 · expire about May 2030

Share count over time

CountShares
Nov 22, 20262,203,250

Open Cap table

Shareholders

Funds

HolderSharesOf the companyValueAs of
Fidelity Extended Market Index Fund143K6.6%US$61,068May 31, 2026
Fidelity Series Total Market Index Fund8,4230.39%US$3,605May 31, 2026
Fidelity Total Market Index Fund3,8960.18%US$1,667May 31, 2026

Big stakes

StakeStakeSharesDateFiling
Mitchell P. Kopin9.99%1.48MDec 31, 2025Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Leonard M Schiller
Other companies: Creatd Inc. (Director · Feb 5, 2016 – Dec 18, 2020 · Past); Milestone Scientific, Inc. (Director · Jun 5, 2008 – Jun 13, 2022 · Past)
Director · Jul 30, 2014 – Jan 1, 2015 · Past
Wayne D. Linsley
Other companies: Myseum.AI, Inc. (Director · Since at least Jan 14, 2025); Hoth Therapeutics, Inc. (Director · Jul 17, 2023 – Aug 19, 2024 · Past)
Board Member · Since at least May 23, 2025
Daniel E RyweckChief Financial Officer · Since at least May 23, 2025
Donald PtalisCFO, Director · Jan 2, 2013 – Jan 2, 2013 · Past
Eric WeisblumChief Executive Officer, Director · Since at least Nov 16, 2023
James KuoVice President of R&D · Since at least Nov 5, 2026
Jeff Pavell D.O.Member · Since at least Nov 4, 2026
Joel Alan StoneDirector · Jul 30, 2014 – Jan 1, 2015 · Past
Kevin MuñozBoard Member · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Silo Pharma, Inc.